Synonyms: Dothep® | dothiepin | Prothiaden®
dosulepin is an approved drug
Compound class:
Synthetic organic
Comment: Dosulepin is a tricyclic antidepressant. Functionally it acts as a serotonin-norepinephrine reuptake inhibitor (SNRI) with anticholinergic, antihistamine, and antiadrenergic effects.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖View more information in the IUPHAR Pharmacology Education Project: dosulepin |
|
No information available. |
Summary of Clinical Use |
Dosulepin is primarily used for the treatment of major depressive disorder [1], but may also be used to treat neuropathic pain and psychogenic facial pain. However, there is no information regarding marketing approval for this drug on the US FDA or European Medicines Agency (EMA) websites. Individual national approval agencies may have granted marketing authorisation. |
Mechanism Of Action and Pharmacodynamic Effects |
Dosulepin acts as a serotonin and norepinephrine reuptake inhibitor. This drug also has anticholinergic, antihistaminic and α1 adrenoceptor antagonist activity [5]. |